Skip to main content
Fig. 5 | Alzheimer's Research & Therapy

Fig. 5

From: Combination of plasma amyloid beta(1-42/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology

Fig. 5

Associations of plasma biomarkers with cognitive performance across the total study cohort, presented as standardized effect sizes with 95% confidence intervals of age, sex, and education (according to Verhage (1965) system) adjusted linear regression analysis between plasma biomarker levels and cognitive domain scores. Plasma Abeta(1-42/1-40) levels were inverted prior to analysis, so that the direction of effect sizes are comparable for all markers. Abeta, amyloid beta; GFAP, glial fibrillary acidic protein; NfL, neurofilament light

Back to article page